InvestorsHub Logo
Followers 278
Posts 9145
Boards Moderated 1
Alias Born 08/07/2018

Re: None

Friday, 04/12/2024 10:24:28 AM

Friday, April 12, 2024 10:24:28 AM

Post# of 198277
$ENZC They have to file by next week on the latest Quaterly , late notice was April 1 , so per OTC regulations thye have fifteen days to file.
--
This latest PR out today is really just restating except for a few things what was put out prior.
https://www.accesswire.com/852524/update-on-formulation-of-new-business-strategy
--
1. This statement from new CEO of ENZC Steve Sharabura (past RobestoMed)
"Steve Sharabura, Interim CEO stated, "The board and I have made progress and have narrowed our target acquisitions and markets to pursue our new business strategy. We have reached out to several entities as potential transaction candidates, including the possible acquisition of technologies previously developed by ENZC. We have also begun discussions for license agreements on a medical device for administering treatments and another diagnostic test for the detection of cancer. Along with the license opportunity, we are strongly leaning toward two targets that we feel will be a base for an aggressive start. In addition, we have contacted consultants to help us apply for the FINRA corporate action to start the process for the dividend of the SAGA shares received from the sale of the two operating subsidiaries.""
--
a. SAGA is not being traded , delisted so what FINRA action is going to help that .
b. Chandra is not in the picture, CC out , JC out
c. Two Operating Subs SOLD, what were the details in writing and proof of transaction anywhere needs to happen
d. What is ENZC in reality at the end of the day now.
---
Lets see

TIME is an ILLUSION
---
TIMING is an actual ART